liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Adverse events in apheresis: An update of the WAA registry data
Nephrol, Umeå, Sweden.
Bone Marrow Transplant and Apheresis, New South Wales, Australia.
St. Anna, Vienna, Austria.
AKH, Vienna, Austria.
Show others and affiliations
2016 (English)In: Transfusion and apheresis science, ISSN 1473-0502, E-ISSN 1878-1683, Vol. 54, no 1, 14 p.2-15 p.Article, review/survey (Refereed) Published
Abstract [en]

Apheresis with different procedures and devices are used for a variety of indications that may have different adverse events (AEs). The aim of this study was to clarify the extent and possible reasons of various side effects based on data from a multinational registry. The WAA-apheresis registry data focus on adverse events in a total of 50846 procedures in 7142 patients (42% women). AEs were graded as mild, moderate (need for medication), severe (interruption due to the AE) or death (due to AE). More AEs occurred during the first procedures versus subsequent (8.4 and 5.5%, respectively). AEs were mild in 2.4% (due to access 54%, device 7%, hypotension 15%, tingling 8%), moderate in 3% (tingling 58%, urticaria 15%, hypotension 10%, nausea 3%), and severe in 0.4% of procedures (syncope/hypotension 32%, urticaria 17%, chills/fever 8%, arrhythmia/asystole 4.5%, nausea/vomiting 4%). Hypotension was most common if albumin was used as the replacement fluid, and urticaria when plasma was used. Arrhythmia occurred to similar extents when using plasma or albumin as replacement. In 64% of procedures with bronchospasm, plasma was part of the replacement fluid used. Severe AEs are rare. Although most reactions are mild and moderate, several side effects may be critical for the patient. We present side effects in relation to the procedures and suggest that safety is increased by regular vital sign measurements, cardiac monitoring and by having emergency equipment nearby.

Place, publisher, year, edition, pages
Elsevier, 2016. Vol. 54, no 1, 14 p.2-15 p.
National Category
Hematology
Identifiers
URN: urn:nbn:se:liu:diva-135128DOI: 10.1016/j.transci.2016.01.003ISI: 000374614700002PubMedID: 26776481OAI: oai:DiVA.org:liu-135128DiVA: diva2:1079874
Available from: 2017-03-09 Created: 2017-03-09 Last updated: 2017-11-29Bibliographically approved

Open Access in DiVA

fulltext(1038 kB)14 downloads
File information
File name FULLTEXT01.pdfFile size 1038 kBChecksum SHA-512
3d13a297da1ee83d7ed5c5b2744c69d5e9759de40cff6483027e6cb50f37584ca26353dadff6029a97fd745076a080b083530e1c880adc2d1bbd344020b5a1e4
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Authority records BETA

Berlin, Gösta

Search in DiVA

By author/editor
Berlin, Gösta
By organisation
Division of Neuro and Inflammation ScienceFaculty of Medicine and Health SciencesDepartment of Clinical Immunology and Transfusion Medicine
In the same journal
Transfusion and apheresis science
Hematology

Search outside of DiVA

GoogleGoogle Scholar
Total: 14 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 33 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf